🔗 Permalink

Inventor profile of:

Jie Fu

City:

Baltimore, Maryland

Country:

United States

Published Applications:

Last publication date:

2023-11-16

Top Assignees for applications by Jie Fu

The entities that hold a legal rights for patent applications filed by inventor Fu Jie:

THE JOHNS HOPKINS UNIVERSITY 10 Baltimore, MD United States
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE 1 Baltimore, MD United States
Kala Pharmaceuticals, Inc. 1 Waltham, MA United States
JOHNS HOPKINS UNIVERSITY 1 Baltimore, MD United States

Recent patent applications by Fu Jie

Jie Fu from Baltimore, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-11-16

US20230364247A1

Human necessities

NON-LINEAR MULTIBLOCK COPOLYMER-DRUG CONJUGATES FOR THE DELIVERY OF ACTIVE AGENTS

#2 | 2023-06-22

US20230190656A1

Human necessities

COMPOSITIONS AND METHODS RELATING TO REDUCED MUCOADHESION

#3 | 2023-03-16

US20230081539A1

Human necessities

SUPRACHOROIDAL DELIVERY OF DRUG PARTICLES TO REDUCE TOXICITY

#4 | 2022-11-24

US20220370371A1

Human necessities

GLUTAMINASE INHIBITOR DISCOVERY AND NANOPARTICLE-ENHANCED DELIVERY FOR CANCER THERAPY

#5 | 2021-08-19

US20210251959A1

Human necessities

SUNITINIB FORMULATIONS AND METHODS FOR USE THEREOF IN TREATMENT OF GLAUCOMA

#6 | 2021-06-17

US20210177979A1

Human necessities

Non-linear multiblock copolymer-drug conjugates for the delivery of active agents

#7 | 2021-02-25

US20210052507A1

Human necessities

DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS

#8 | 2020-08-06

US20200246274A1

Human necessities

Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy

#9 | 2020-05-14

US20200147044A1

Human necessities

Sunitinib formulations and methods for use thereof in treatment of glaucoma

#10 | 2020-03-12

US20200078304A1

Human necessities

COMPOSITIONS AND METHODS RELATING TO REDUCED MUCOADHESION

#11 | 2019-09-12

US20190275001A1

Human necessities

SUNITINIB FORMULATIONS AND METHODS FOR USE THEREOF IN TREATMENT OF OCULAR DISORDERS

#12 | 2019-03-07

US20190070302A1

Human necessities

Non-linear multiblock copolymer-drug conjugates for the delivery of active agents

#13 | 2018-12-06

US20180344656A1

Human necessities

DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS

#14 | 2017-12-21

US20170360750A1

Human necessities

Sunitinib formulations and methods for use thereof in treatment of glaucoma

#15 | 2017-09-28

US20170273901A1

Human necessities

SUNITINIB FORMULATIONS AND METHODS FOR USE THEREOF IN TREATMENT OF OCULAR DISORDERS

#16 | 2017-07-27

US20170209387A1

Human necessities

Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy

#17 | 2017-01-12

US20170007542A1

Human necessities

COMPOSITIONS AND METHODS RELATING TO REDUCED MUCOADHESION

#18 | 2016-09-08

US20160256404A1

Human necessities

Drugs and Gene Carrier Particles That Rapidly Move Through Mucous Barriers

#19 | 2015-05-21

US20150141359A1

Human necessities

Controlled release formulations for the delivery of HIF-1 inhibitors

#20 | 2013-10-17

US20130274217A1

Human necessities

Controlled release formulations for the delivery of HIF-1 inhibitors

#21 | 2013-10-17

US20130272994A1

Human necessities

Non-linear multiblock copolymer-drug conjugates for the delivery of active agents

#22 | 2013-09-12

US20130236556A1

Human necessities

COMPOSITIONS AND METHODS RELATING TO REDUCED MUCOADHESION

#23 | 2010-01-07

US20100003337A1

Human necessities

Functionalized poly(ether-anhydride) block copolymers

#24 | 2008-07-10

US20080166414A1

Human necessities

Drugs and gene carrier particles that rapidly move through mucous barriers

#25 | 2007-01-16

US10177748

Biodegradable polymer compositions, compositions and uses related thereto

InventorID:

433006 ⎘